In 2008, Springer acquired open access publisher BioMed Central amid worries the publisher would curtail the open access model despite claims at the time that they viewed open access as a viable business model and expected to expand the operation. This week, the company announced an expansion of the open access model to all disciplines under the trade name SpringerOpen.
From their press release:
SpringerOpen (www.springeropen.com) will cover all disciplines within the science, technology and medicine (STM) fields and will be offered in cooperation with BioMed Central. The entire content of SpringerOpen journals – including research articles, reviews, and editorials – are fully and immediately open access, and are accessible to anyone with an internet connection. No subscription is needed.
“We are seeing an increasing interest from our authors and from funders in all areas for open access publishing options and have responded to a need in the current market,” said Wim van der Stelt, EVP Business Development, Springer. “We are happy to serve our authors and editorial boards with the publishing options they want and are also pleased to supply universities, research institutions and our other patrons with the ability to use this content online freely and conveniently.”
SpringerOpen journals are e-only journals. Springer is committed to delivering high-quality articles and ensuring rapid publication as with its traditional journals, from online submission systems and in-depth peer review to an efficient, author-friendly production process. The final articles are not only published in a timely manner on Springer’s online information platform SpringerLink, but are also distributed to archives such as PubMed Central and to institutional repositories as requested.
SpringerOpen journals are published under the Creative Commons Attribution license, which facilitates the open distribution of copyrighted work. According to this license, Springer will not reserve any exclusive commercial rights. The journals ask the authors to pay an article-processing charge, in accordance with market standards.
BioMed Central, acquired in 2008 by Springer, will provide its expertise and technology to help establish the SpringerOpen portfolio. SpringerOpen journals will publish in emerging and interdisciplinary fields and will complement both the established Springer journal portfolios and BioMed Central’s growing list of over 200 life science and biomedicine journal titles. Furthermore, in order to reduce the financial burden faced by individual authors, Springer and BioMed Central are collaborating to extend BioMed Central’s Open Access Membership scheme, offered to institutions, societies, groups, funders and corporations, to include the SpringerOpen titles. More than 300 institutional open access membership arrangements are currently in place.
Springer Science+Business Media (www.springer.com) is a leading global scientific publisher, delivering quality content through innovative information products and services. The company is also a trusted provider of local-language professional publications in Europe, especially in Germany and the Netherlands. In the science, technology and medicine (STM) sector, the group publishes around 2,000 journals and more than 6,500 new books a year, as well as the largest STM eBook Collection worldwide. Springer has operations in about 20 countries in Europe, the USA, and Asia, and more than 5,000 employees.
BioMed Central (www.biomedcentral.com) has been part of Springer Science+Business Media since 2008. Founded in 1999, the STM publisher has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is the largest open access publisher in the world.